SCHEDULE 13D

Company

PULSE BIOSCIENCES, INC.

Filed

June 1, 2016

Accession Number

0001144204-16-105992

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →